Heartsanjivani Centre'S Nectar The Cancer Institute Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 11 Months
- Last Filing with ROC 31 Mar 2024
About Heartsanjivani Centre'S Nectar The Cancer Institute
Heartsanjivani Centre's Nectar The Cancer Institute Private Limited (HCNTCIPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 February 2023 (One year and 11 months 18 days old ). Its registered office is in Nashik, Maharashtra, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vijaya Patil, Chandrasen Patil, and Sanjay Patil serve as directors at the Company.
Company Details
-
Location
Nashik, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U86909MH2023PTC398133
-
Company No.
398133
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Feb 2023
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Who are the key members and board of directors at Heartsanjivani Centre'S Nectar The Cancer Institute?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijaya Patil
|
Director | 15-Feb-2023 | Current |
|
Chandrasen Patil
|
Director | 15-Feb-2023 | Current |
|
Sanjay Patil
|
Director | 15-Feb-2023 | Current |
Financial Performance of Heartsanjivani Centre'S Nectar The Cancer Institute.
Enhance accessibility to Heartsanjivani Centre'S Nectar The Cancer Institute's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Heartsanjivani Centre'S Nectar The Cancer Institute?
Unlock access to Heartsanjivani Centre'S Nectar The Cancer Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Heartsanjivani Multimedical Research Institute Private LimitedVijaya Patil and Chandrasen Patil are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Heartsanjivani Centre'S Nectar The Cancer Institute?
Unlock and access historical data on people associated with Heartsanjivani Centre'S Nectar The Cancer Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Heartsanjivani Centre'S Nectar The Cancer Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heartsanjivani Centre'S Nectar The Cancer Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.